|
US715368A
(en)
|
1902-05-29 |
1902-12-09 |
Isaac N Graham |
Cutter-bar for harvesters or mowers.
|
|
US4215051A
(en)
|
1979-08-29 |
1980-07-29 |
Standard Oil Company (Indiana) |
Formation, purification and recovery of phthalic anhydride
|
|
US5567610A
(en)
|
1986-09-04 |
1996-10-22 |
Bioinvent International Ab |
Method of producing human monoclonal antibodies and kit therefor
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5175384A
(en)
|
1988-12-05 |
1992-12-29 |
Genpharm International |
Transgenic mice depleted in mature t-cells and methods for making transgenic mice
|
|
US5229275A
(en)
|
1990-04-26 |
1993-07-20 |
Akzo N.V. |
In-vitro method for producing antigen-specific human monoclonal antibodies
|
|
US5565332A
(en)
|
1991-09-23 |
1996-10-15 |
Medical Research Council |
Production of chimeric antibodies - a combinatorial approach
|
|
WO1993016177A1
(en)
|
1992-02-11 |
1993-08-19 |
Cell Genesys, Inc. |
Homogenotization of gene-targeting events
|
|
US5573905A
(en)
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
|
IT1263831B
(it)
|
1993-01-29 |
1996-09-04 |
Paolo Chiesi |
Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina
|
|
SE502408C2
(sv)
|
1993-09-30 |
1995-10-16 |
Dataliner Ab |
Skalmönster vid lägesbestämning med hjälp av en snäv mätstråle
|
|
US5888767A
(en)
|
1996-11-27 |
1999-03-30 |
The Johns Hopkins University School Of Medicine |
Method of using a conditionally replicating viral vector to express a gene
|
|
EP1415982A1
(en)
|
1998-03-11 |
2004-05-06 |
G.D. SEARLE & CO. |
Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors
|
|
AUPP616498A0
(en)
|
1998-09-25 |
1998-10-15 |
University Of Queensland, The |
Synthesis of cyclic peptides
|
|
US7024312B1
(en)
|
1999-01-19 |
2006-04-04 |
Maxygen, Inc. |
Methods for making character strings, polynucleotides and polypeptides having desired characteristics
|
|
US6703491B1
(en)
*
|
1999-03-17 |
2004-03-09 |
Exelixis, Inc. |
Drosophila sequences
|
|
US20040031072A1
(en)
*
|
1999-05-06 |
2004-02-12 |
La Rosa Thomas J. |
Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
|
|
ATE340571T1
(de)
|
2000-01-18 |
2006-10-15 |
Univ Mcgill |
Pharmazeutische zubereitungen enthaltend beta- turn peptidomimetische zyklische substanzen
|
|
US6495674B1
(en)
|
2000-02-25 |
2002-12-17 |
The Salk Institute For Biological Studies |
Evectins and their use
|
|
US7252952B2
(en)
|
2000-03-06 |
2007-08-07 |
Rigel Pharmaceuticals, Inc. |
In vivo production of cyclic peptides for inhibiting protein—protein interaction
|
|
US6417237B1
(en)
|
2000-06-08 |
2002-07-09 |
The Board Of Trustees Of The University Of Illinois |
Macromolecular drug complexes and compositions containing the same
|
|
EP1385544B1
(en)
*
|
2001-04-30 |
2008-09-24 |
Eli Lilly And Company |
Humanized antibodies
|
|
KR100566911B1
(ko)
|
2001-06-25 |
2006-04-03 |
주식회사 삼양사 |
약물 전달체용 음이온기-함유 양친성 블록 공중합체 및 그의 양이온성 약물과의 복합체
|
|
US20040142325A1
(en)
*
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
|
US7084257B2
(en)
|
2001-10-05 |
2006-08-01 |
Amgen Inc. |
Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
|
|
SI1461359T1
(sl)
*
|
2002-01-18 |
2007-06-30 |
Pf Medicament |
Nova anti IGF-IR protitelesa in njihova uporaba
|
|
US7153685B2
(en)
|
2002-03-11 |
2006-12-26 |
The Board Of Trustees Of The University Of Illinois |
Tamoxifen and 4-hydroxytamoxifen-activated system for regulated production of proteins in eukaryotic cells
|
|
AU2003232872A1
(en)
|
2002-05-27 |
2003-12-12 |
Ostergotlands Lans Landsting |
Method for determining immune system affecting compounds
|
|
CA2488441C
(en)
|
2002-06-03 |
2015-01-27 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
|
US7538195B2
(en)
*
|
2002-06-14 |
2009-05-26 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
|
WO2004022097A1
(en)
*
|
2002-09-05 |
2004-03-18 |
Medimmune, Inc. |
Methods of preventing or treating cell malignancies by administering cd2 antagonists
|
|
US20090183270A1
(en)
*
|
2002-10-02 |
2009-07-16 |
Adams Thomas R |
Transgenic plants with enhanced agronomic traits
|
|
US20040208921A1
(en)
|
2003-01-14 |
2004-10-21 |
Ho Rodney J. Y. |
Lipid-drug formulations and methods for targeted delivery of lipid-drug complexes to lymphoid tissues
|
|
EP1613774A2
(en)
|
2003-03-10 |
2006-01-11 |
Applera Corporation |
Genetic polymorphisms associated with stenosis, methods of detection and uses thereof
|
|
CA2520846C
(en)
|
2003-03-31 |
2013-09-24 |
Mcmaster University |
Aptamer selection method
|
|
AU2003902875A0
(en)
*
|
2003-06-10 |
2003-06-26 |
The University Of Melbourne |
Immunomodulating compositions, uses therefor and processes for their production
|
|
KR20130065723A
(ko)
|
2003-06-27 |
2013-06-19 |
암젠 프레몬트 인코포레이티드 |
상피 성장 인자 수용체의 결실 돌연변이체 지향 항체 및 그 용도
|
|
ES2383300T3
(es)
|
2003-11-13 |
2012-06-20 |
Hanmi Holdings Co., Ltd |
Fragmento Fc de IgG para un vehículo de fármacos y procedimiento para su preparación
|
|
NZ579482A
(en)
|
2004-06-01 |
2011-02-25 |
Genentech Inc |
Antibody drug conjugates and methods
|
|
KR101131727B1
(ko)
|
2004-06-11 |
2012-03-28 |
가톨릭대학교 산학협력단 |
ＣＥＡ-특이적인 세포독성 Ｔ세포를 생성하는 재조합 아데노바이러스 ＡｄＶＣＥＡ로 트랜스덕션된 수지상세포, 이를 포함하는 백신 및 약제학적 조성물
|
|
FR2873699B1
(fr)
|
2004-07-29 |
2009-08-21 |
Pierre Fabre Medicament Sa |
Nouveaux anticorps anti igf ir rt leurs utilisations
|
|
SE0402536D0
(sv)
|
2004-10-20 |
2004-10-20 |
Therim Diagnostica Ab |
Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
|
|
EP1875246B1
(en)
|
2005-04-15 |
2016-10-05 |
CanImGuide Therapeutics AB |
Diagnostic method for detecting cancer by measuring amount of a cytokine like il-6
|
|
CN101400646A
(zh)
|
2005-11-08 |
2009-04-01 |
Ambrx公司 |
用于修饰非天然氨基酸和非天然氨基酸多肽的促进剂
|
|
WO2007070659A2
(en)
|
2005-12-14 |
2007-06-21 |
Ambrx, Inc. |
Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
|
|
US7812133B2
(en)
|
2005-12-16 |
2010-10-12 |
Genentech, Inc |
Anti-OX40L antibodies and methods using same
|
|
US7816324B2
(en)
|
2007-03-13 |
2010-10-19 |
Board Of Regents, The University Of Texas System |
Composition and method for the treatment of diseases affected by a peptide receptor
|
|
ES2608803T3
(es)
*
|
2007-05-08 |
2017-04-17 |
Canimguide Therapeutics Ab |
Estructuras inmunorreguladoras procedentes de proteínas naturales
|
|
WO2009047360A1
(en)
*
|
2007-10-11 |
2009-04-16 |
Novo Nordisk A/S |
Il-21 antibodies
|
|
RU2360924C1
(ru)
*
|
2007-12-21 |
2009-07-10 |
Институт биохимии им. А.А. Баха РАН |
Маркер рака предстательной железы
|
|
EP4012714A1
(en)
|
2010-03-23 |
2022-06-15 |
Iogenetics, LLC. |
Bioinformatic processes for determination of peptide binding
|
|
US8455624B2
(en)
*
|
2011-06-03 |
2013-06-04 |
University Of South Alabama |
Methods and compositions for detecting endometrial or ovarian cancer
|
|
EP3043810B1
(en)
|
2013-09-09 |
2019-10-23 |
CanImGuide Therapeutics AB |
Immune system modulators
|
|
WO2016144650A1
(en)
|
2015-03-06 |
2016-09-15 |
Canimguide Therapeutics Ab |
Immune system modulators and compositions
|